Share this

Lobular breast cancer survey now open with aim of identifying UK’s top 10 research priorities

Lobular breast cancer survey now open with aim of identifying UK’s top 10 research priorities

A new survey is now inviting responses in a bid to gather vital perspectives that will help set research priorities around the second most common type of breast cancer.

The James Lind Alliance Priority Setting Partnership (PSP) in Lobular Breast Cancer initial survey is seeking to identify unanswered questions about diagnosis, treatment, and care across the UK from people with lived experience while also encouraging a range of clinical perspectives.

Those leading the James Lind Alliance PSP believe that lobular breast cancer is “currently under-researched and frequently omitted from breast cancer treatment trials”.

They add: “There are currently no tailored treatment pathways in the NHS for lobular breast cancer, and this PSP will address some of the issues around treatment and care, and what further research is needed to inform changes to treatment and care in the UK.”

The PSP will use the responses to identify the top 10 questions for research to answer around this distinct disease. The responses will then be shared with researchers and funders to help drive research that could improve outcomes for all impacted.

Lobular breast cancer begins in the milk-producing glands of the breast – rather than the more typical place of origin in the milk ducts – and spreads into nearby breast tissue or other parts of the body.

Its growth pattern makes it harder to feel as a distinct lump or to see clearly on a standard mammogram.

Lobular breast cancer is the second most common type of breast cancer, accounting for 10% to 15% of all diagnoses, with invasive ductal carcinoma (IDC) making up the majority of cases.

The UK sees around 22 diagnoses per day, making it more common than ovarian, cervical, kidney, brain, liver, or pancreatic cancers.

• Take the survey

The survey is part of the Unlocking Lobular: Lobular Breast Cancer Priority Setting Partnership led by Lobular Breast Cancer UK and De Montfort University and supported by the James Lind Alliance.

Publication date: 19th November 2026

Author: NHS Research Scotland